Fig. 2From: Impact of selective LDL apheresis on serum chemerin levels in patients with hypercholesterolemiaChanges in serum chemerin levels of a patient (P2) measured before LDL apheresis sessions during a 12-month period. Treatment has been suspended for three months (labelled with dotted line)Back to article page